| In millions, except per share items | Jun-30-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| | 10-Q | 10-K | 8-K | 10-Q | 10-Q | 10-K | 10-Q | 10-Q |
| Revenues: |
| Product revenue | | | 39.6 | | | | | |
| Research and development | | | 16.2 | | | | | |
| Total revenues [+] | 0.0 | 24.8 | 55.8 | 0.0 | 0.0 | 68.5 | 36.1 | 0.0 |
| Royalties | | | 16.2 | | | | | |
| Products | | | 39.6 | | | | | |
| Revenue growth | | -63.8% | 54.4% | | | 35.6% | 53.1% | -100.0% |
| Cost of goods sold | 0.0 | 55.5 | 17.7 | 0.0 | -69.6 | 44.0 | 17.6 | 0.0 |
| Gross profit | 0.0 | -30.6 | 38.1 | 0.0 | 69.6 | 24.5 | 18.5 | 0.0 |
| Gross margin | | -123.5% | 68.3% | | -267530.8% | 35.8% | 51.3% | |
| Selling, general and administrative [+] | 41.9 | 87.3 | 19.9 | 34.7 | 34.8 | 85.7 | 20.4 | 36.8 |
| General and administrative | | 87.3 | | | | 85.7 | | |
| Research and development | 19.2 | 64.1 | | 15.2 | 14.1 | 15.6 | 15.3 | 17.1 |
| Other operating expenses | -46.2 | -155.6 | 25.7 | -40.2 | 35.0 | -59.5 | -6.0 | -37.8 |
| EBITDA [+] | | -24.0 | | -9.0 | -13.4 | -17.0 | -10.4 | -15.4 |
| EBITDA growth | 64.1% | 40.6% | -28.1% | -41.3% | -24.2% | 0.7% | -21.3% | 11.3% |
| EBITDA margin | | -96.6% | -13.3% | | 51623.1% | -24.9% | -28.7% | |
| Depreciation and amortization | | 2.5 | | 0.8 | 0.9 | 0.2 | 0.8 | 0.8 |
| EBIT [+] | -14.8 | -26.5 | -7.4 | -9.8 | -14.3 | -17.2 | -11.1 | -16.2 |
| EBIT growth | 51.3% | 53.8% | -33.1% | -39.4% | -22.7% | 2.3% | -20.4% | 10.7% |
| EBIT margin | | -106.7% | -13.3% | | 54950.0% | -25.1% | -30.8% | |
| Interest expense | | | | | | 3.6 | 1.3 | |
| Interest expense | 2.2 | | | 1.3 | 1.4 | 3.6 | 1.3 | 1.3 |
| Other income (expense), net [+] | 3.8 | 13.1 | -1.0 | 2.8 | 3.5 | 11.7 | 0.0 | 2.2 |
| Gain (loss) on foreign currency transactions | | | | | | 0.4 | -0.2 | |
| Change in fair value of warrants | | | | | 0.3 | | | |
| Other | | | | | | | 0.2 | |
| Pre-tax income | -13.2 | -13.4 | -8.5 | -8.3 | -12.2 | -9.1 | -12.4 | -15.3 |
| Income taxes | 0.1 | 0.3 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Tax rate | | | | | | | | |
| Minority interest | | 0.0 | 0.0 | | | | | |
| Net income | -13.3 | -13.6 | -8.5 | -8.4 | -12.3 | -9.1 | -12.4 | -15.4 |
| Net margin | | -54.9% | -15.2% | | 47246.2% | -13.3% | -34.4% | |
| |
| Basic EPS [+] | ($0.07) | ($0.08) | ($0.05) | ($0.05) | ($0.07) | ($0.05) | ($0.07) | ($0.09) |
| Growth | 55.0% | 44.9% | -33.9% | -47.1% | -31.9% | -39.3% | -14.8% | -0.8% |
| Diluted EPS [+] | ($0.07) | ($0.08) | ($0.05) | ($0.05) | ($0.07) | ($0.05) | ($0.07) | ($0.09) |
| Growth | 55.0% | 44.9% | -33.9% | -47.1% | -31.9% | -39.3% | -14.8% | -0.8% |
| |
| Shares outstanding (basic) [+] | 180.6 | 176.5 | 177.2 | 176.9 | 174.5 | 171.3 | 171.9 | 171.2 |
| Growth | 2.1% | 3.1% | 3.1% | 3.3% | 3.3% | 4.5% | 3.2% | 4.2% |
| Shares outstanding (diluted) [+] | 180.6 | 176.5 | 177.2 | 176.9 | 174.5 | 171.3 | 171.9 | 171.2 |
| Growth | 2.1% | 3.1% | 3.1% | 3.3% | 3.3% | 4.5% | 3.2% | 4.2% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |